The invention relates to compounds of the general formula (I) which are inhibitors of purine nucleoside phosphorylases (PNPs) and/or nucleoside hydrolases (NHs). The invention also relates to the use of these compounds in the treatment of diseases and infections including cancer, bacterial infections, protozoal infections, and T-cell mediated disease and to pharmaceutical compositions containing the compounds.
本发明涉及通式(I)化合物,它们是
嘌呤核苷
磷酸酶(
PNPs)和/或核苷
水解酶(NHs)的
抑制剂。本发明还涉及这些化合物在治疗疾病和感染(包括癌症、细菌感染、原生动物感染和 T 细胞介导的疾病)中的用途,以及含有这些化合物的药物组合物。